SK Life Science, Inc. Selects Patheon as Development Services Partner for...
CNW Group via Yahoo! Finance: 1 views since Tuesday, July 8, 2008 at 07:00 AM
Patheon , a global provider of drug development and manufacturing services to the international pharmaceutical industry, is pleased to have been selected by SK Life Science, Inc. , the US-based subsidiary of Korean SK Holdings as their development services partner for two additional innovative Central Nervous System drug candidates.

Published in: Chemical Services and Supplies